Explore more publications!
STEM News Today
Got News to Share?

STEM News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM News Today.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on January 23, 2026

Kaamos Labs Launches Polaris Focus, a Neuroscience-Inspired App
Jan. 23, 2026

Kaamos Labs Launches Polaris Focus, a Neuroscience-Inspired App

Indeterminate EIN Presswire
Food Journal Magazine Is Shaping the Conversation Around Los Angeles Food in 2026
Jan. 23, 2026

Food Journal Magazine Is Shaping the Conversation Around Los Angeles Food in 2026

Indeterminate EIN Presswire
NBCI and ACHDC Issue a Call for Scientific Papers on Improving Black Health for the Enroll Now Online Magazine
Jan. 23, 2026

NBCI and ACHDC Issue a Call for Scientific Papers on Improving Black Health for the Enroll Now Online Magazine

Indeterminate EIN Presswire
Scientists Highlight the Hidden Stress Chemistry of Big Sporting Events — and Why Alcohol May be a Poor Way to Cope
Jan. 23, 2026

Scientists Highlight the Hidden Stress Chemistry of Big Sporting Events — and Why Alcohol May be a Poor Way to Cope

Indeterminate EIN Presswire
Sunrider’s Kandesn® Pure Bio Cellulose Mask Wins Silver at 2026 Veggie Awards
Jan. 23, 2026

Sunrider’s Kandesn® Pure Bio Cellulose Mask Wins Silver at 2026 Veggie Awards

Indeterminate EIN Presswire
RTW Foundation donates $8 million to reimagine physician training in Penn’s Perelman School of Medicine
Jan. 23, 2026

RTW Foundation donates $8 million to reimagine physician training in Penn’s Perelman School of Medicine

Indeterminate EIN Presswire
Choroideremia Research Foundation Acquires Spark Therapeutics, Inc., CHM Gene Therapy Assets, Advances Data Analysis
Jan. 23, 2026

Choroideremia Research Foundation Acquires Spark Therapeutics, Inc., CHM Gene Therapy Assets, Advances Data Analysis

Indeterminate EIN Presswire
Fobi AI Announces Completion of First Tranche Of Non-Brokered Private Placement
Jan. 23, 2026

Fobi AI Announces Completion of First Tranche Of Non-Brokered Private Placement

Indeterminate GlobeNewswire
How Consumers Evaluate Heated Wearable Gear Reliability During Extreme Cold Events
Jan. 23, 2026

How Consumers Evaluate Heated Wearable Gear Reliability During Extreme Cold Events

Indeterminate GlobeNewswire
LEADING EDGE MATERIALS REPORTS FISCAL 2025 RESULTS
Jan. 23, 2026

LEADING EDGE MATERIALS REPORTS FISCAL 2025 RESULTS

Indeterminate GlobeNewswire
CRWV INVESTOR REMINDER: Coreweave, Inc. Investors Have Until March 13, 2026 To Seek Lead Plaintiff Role - Kirby McInerney LLP
Jan. 23, 2026

CRWV INVESTOR REMINDER: Coreweave, Inc. Investors Have Until March 13, 2026 To Seek Lead Plaintiff Role - Kirby McInerney LLP

Indeterminate GlobeNewswire
WLTH SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
Jan. 23, 2026

WLTH SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

Indeterminate GlobeNewswire
Domestic Metals Engages ICP Securities Inc. for Automated Market Making Services and provides further details on the engagement of Michael Pound
Jan. 23, 2026

Domestic Metals Engages ICP Securities Inc. for Automated Market Making Services and provides further details on the engagement of Michael Pound

Indeterminate GlobeNewswire
Protecting Football Players’ Brains: Breakthrough Study Reinforces Vielight’s Red-Light Therapy Technology
Jan. 23, 2026

Protecting Football Players’ Brains: Breakthrough Study Reinforces Vielight’s Red-Light Therapy Technology

Indeterminate GlobeNewswire
Immunovant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026
Jan. 23, 2026

Immunovant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026

Indeterminate GlobeNewswire
NuVista and Ovintiv Announce NuVista Shareholder Approval and Receipt of Final Order for Transaction with Ovintiv and Preliminary Results of Elections by NuVista Shareholders Regarding Form of Consideration
Jan. 23, 2026

NuVista and Ovintiv Announce NuVista Shareholder Approval and Receipt of Final Order for Transaction with Ovintiv and Preliminary Results of Elections by NuVista Shareholders Regarding Form of Consideration

Indeterminate GlobeNewswire
Corvus Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $201M
Jan. 23, 2026

Corvus Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $201M

Indeterminate GlobeNewswire
Technology Innovation Institute Calls for System-Level Thinking in Deep Tech at Davos
Jan. 23, 2026

Technology Innovation Institute Calls for System-Level Thinking in Deep Tech at Davos

Indeterminate EIN Presswire
Cineplex Responds to Federal Court of Appeal Decision
Jan. 23, 2026

Cineplex Responds to Federal Court of Appeal Decision

Indeterminate GlobeNewswire
MEDIROM Forms New Special Mission Team to Drive World ID Adoption Across 3,000 Locations Through Partnership with Tools for Humanity
Jan. 23, 2026

MEDIROM Forms New Special Mission Team to Drive World ID Adoption Across 3,000 Locations Through Partnership with Tools for Humanity

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions